Clinical trial

Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum…

NCT00278772 · Lindner Center of HOPE, Other · Completed

Key facts

NCT number NCT00278772
Title Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania
Official title "A Randomized, Double-Blind, Placebo-Controlled Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania"
Lead sponsor Lindner Center of HOPE, Other
Collaborators Abbott Industry University of Cincinnati
Status Completed
Phase Phase 3
Study type Interventional
Conditions Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania
Intervention type Drug, Other
Interventions Divalproex, Placebo
Enrollment 62
Start date Aug 1, 2003
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Jan 18, 2006
Last update posted May 26, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies